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Abstract
Multiple Sclerosis (MS) is a neurological disorder that affects about one million people in the United States. The disease results
from an abnormal immune response where T cells damage the myelin sheath in the central nervous system, causing scarring.The
lesions can occur in any part of the brain or spinal cord, and thus affects every patient differently. One of the most detrimental
effects the disease has on patients’ lives is the decreased ability to walk. There has been research and treatments to manage
pain and slow progression of the disease, but little progress has been made to enable MS patients to walk more comfortably.
Previously, there have been gait training devices in use. However, many require intensive manual labor which causes the patient
and the physical therapist to fatigue easily. Recently, Ekso, a self-supporting robotic exoskeleton, designed for patients with spinal
cord damage, has been shown to improve gait and overall quality of life in patients with MS.
Introduction
Multiple Sclerosis is a degenerative neurological disease
affecting the Central Nervous System. Unfortunately, it
affects many younger people, mostly diagnosed in women
between the ages of 20 and 50. There is often physical
and emotional pain associated with the disease. There are
various medications in use that can treat those symptoms
and help improve the patients’ quality of life (Ziemssen,
2011). However, change in natural gait is a consequence of
MS that disrupts patients’ daily lives. Over time, a patient’s
ability to walk deteriorates. Progressive worsening of gait is
self-reported and is also demonstrated through data measured on various scales by researchers (Motl, et al., 2018).
Robotic exoskeletons have been shown as an effective way
to retrain gait. Exoskeletons are designed to mimic the
movements of human limbs.They attach to the extremities
and can control the position and alignment of the joints.
Exoskeletons can also be programmed to provide support
based on the patient’s motor capabilities (Iandolo, et al.,
2019).This paper discusses the pathology and musculoskeletal effects of MS and examines the effectiveness of robotic
exoskeletons in improving gait of MS patients.
Methods
The information in this review is collected from various
academic and scientific articles obtained from the EBSCO,
PubMed, and ProQuest databases accessed through the
Touro College library. Each article was analyzed in order
to determine its relevance to the thesis.
Discussion:
Glial Cells and the Myelin Sheath
The nervous system is made of separate parts that work
in tandem. Included is the central and peripheral nervous
systems. The central nervous system is made up of the
brain and spinal cord while the peripheral nervous system
is composed of the nerves that connect the CNS to the
rest of the body. Although they are not neurons, glia are a
fundamental component of the nervous system. The glial
cells espouse the neurons and enable them to function
properly. Astrocytes are the most common type of glial
cell. Astrocytes fill the spaces between neurons, providing
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support. Astrocytes also contribute to the maintenance
of the chemical balance in the neuron by controlling the
extracellular chemical concentration and assisting in the
reuptake of neurotransmitters. There are also microglia
that are involved in removing debris in the nervous system, ensuring that messages can travel without blockage.
Another type of glial cell is myelinating glia. Myelinating
glia are divided into two subtypes, oligodendrocytes
and Schwann cells. Oligodendrocytes are in the central
nervous system, while Schwann cells are present in the
peripheral nervous system. These cells provide insulation
to the neurons by wrapping around their axons in a covering known as myelin, forming the myelin sheath. Myelin
provides insulation, allowing signals to be transported
faster. There are small gaps in the myelin sheath known as
nodes of Ranvier. When an action potential moves down
an axon it is regenerated at the node of Ranvier in a process known as saltatory conduction (Bear, et al., 1996).
Pathology of MS
Multiple Sclerosis is a condition where the body’s immune
system attacks the myelin sheath. MS usually presents at
first with an attack that lasts between a few days and a
few weeks. It is followed by a period of relief that can
last from a few months to a few years. The reprieve is a
result of an autoimmune reaction. This mild form of MS
usually lasts for about ten years, but varies by case. As the
disease progresses, the attacks become less distinct, and
the patient’s condition greatly deteriorates. During the
later stages of the disease, the underlying axon is damaged in addition to the myelin sheath.The axon loss in the
spinal cord causes spinal cord atrophy which can make
it difficult for the patient to walk and lead to paralysis
(Lucchinetti, et al., 1996).
Many protein sequences on the myelin sheath are similar
to microbial protein sequences. As a result, the immune
system attacks the myelin in a process known as molecular
mimicry. Many relapses of MS occur as a result of infection
from a virus. Herpesvirus 6, influenza, measles, papilloma
virus, and Epstein-Barr virus all have gene encoding sequences that are similar to the main protein structures of
the myelin. Antibodies bind to the myelin instead of the

Can Robotic Exoskeletons Improve Gait in MS Patients?

microbe. If a T-cell or B-cell is activated by the microbe,
it can penetrate the blood-brain barrier (Steinman, 2001).
The diagnosis of MS is a complex process and multiple
factors need to be taken into account. Firstly, there need
to be lesions in the white matter of two separate parts of
the CNS that developed at least a month apart from each
other. All other neurological disorders with similar symptoms need to be ruled out. In addition, an MRI must be
performed. The MRI will display the lesions and successive MRI scans can be a tool to help the physician track
the progression of the disease. It also needs to be determined that the CNS is chronically inflamed, which can be
assessed by a spinal tap. A spinal tap allows the physician
to see if there are oligoclonal bands in the fluid which
indicate neurological disorders. In addition, each episode
of attacks needs to be distinct and last for 24 hours or
more. As the disease progresses, it can be subcategorized
(Garg, Smith, 2015).
MS affects the myelin of the CNS. Each part of the brain
and spinal cord control different neurological functions,
so the effects of the lesions can manifest in different ways.
Relapsing–remitting MS is the most common form of MS.
The person will have separate attacks that can last from
a few days to a few months. In between attacks, there is a
period of reprieve where symptoms get better and there
is no neurological degeneration. The next type of MS is
Secondary Progressive MS (SPMS). In a patient with SPMS,
the condition worsens gradually with time and the patient does not experience any episodes of relief. Primary
progressive MS (PPMS) affects a minority of MS patients.
It is characterized by an unrelenting decline in neurological function. There are no relapses or remissions, but
there are occasional periods where there is no significant
deterioration. Lastly is progressive-relapsing MS (PRMS).
PRMS is the rarest form of MS. From the beginning of
PRMS, the symptoms get progressively worse. However,
it is different from other types of MS because there are
periods where the attacks are more intense and debilitating with no periods of remission (Loma, Heyman, 2011).
In the worst stages of MS, there are no phases of relief,
as there is destruction to the axons and atrophy of the
brain and spinal cord. AMPA is an ionotropic transmembrane receptor for glutamate that allows for fast synaptic transmission in the central nervous system. AMPA
receptors are present on oligodendrocytes. During an
MS attack, lymphocytes, brain microglia and macrophages
release large amounts of glutamate, which activate the
AMPA receptors and cause overstimulation. However, if
the receptors are blocked, it can mitigate some of the
damage from the glutamate. AMPA is not involved in the
immune response, but it can protect the oligodendrocytes

from being damaged. Medications that block glutamate
receptors are being utilized to treat this aspect of MS
(Steinman, 2001).
The Effect of MS on Gait
Since MS affects the spinal cord, the main support of the
body, a patient’s gait can be affected, causing difficulty
walking. Damage to certain areas of the spinal cord can
lead to muscle spasticity. Muscle spasticity is an increase
in rigidity of the muscles. The stiffness can be mild or it
can cause involuntary uncontrolled movements of the
extremities. The stiffness can make straight limbs hard to
bend or bent limbs hard to straighten. Since many MS
patients suffer from fatigue, extreme tiredness can make
coordinating movement challenging. MS patients can also
suffer from weakness in the leg muscles, altering normal
stride. The change in walking pattern can cause pain, furthering the difficulty of walking (nationalmssociety.org).
MS patients can also suffer from balance issues, affecting their ability to walk properly. The balance issues can
be caused by many different factors, such as vision and
sensory issues. A patient may have reduced visual acuity
or lack proper depth perception. This can be hazardous
to a patient because it affects their ability to be aware of
their surroundings. MS-related sensory issues can cause
numbness which results from reduced muscle spindle and
joint receptor activity. This can lead to decreased sensation in the feet which compromises stability and makes
it difficult to navigate uneven surfaces. There is also the
vestibular impact of MS on balance.The vestibulocochlear
nerve is responsible for both hearing and balance. In MS
patients, the vestibulo-ocular reflex is reduced, affecting
the ability to stabilize gaze, causing dizziness and unsteadiness (nationalmssociety.org).
Motor systems can also be affected by MS. Patients with
MS often have decreased muscle strength and endurance.
This makes it difficult for patients to use a wheelchair or
scooter on their own. There are also issues with muscle
control and range of motion. This can lead to an inability
to anticipate changes in the environment, resulting in an
increased response time. Patients may also over or under
compensate with other muscles in order to make up for
the decreased function. These issues can lead to uneven
gait (nationalmssociety.org).
Neurological Impact of MS on Gait
A study was done with patients in the early stages of MS
to assess the way gait is affected by neurological deficits.
Depending on how the gait and neurological systems are
impaired, gait patterns will be different among patients and
even differ in the same patient over time. Disturbance of
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normal gait is reported as the most debilitating symptom
by MS patients. The gait of MS patients was compared to
a control group of healthy people. MS patients walked
slower and used shorter steps. In addition to walking less
efficiently overall, there was a decrease in velocity and
stride length over the course of the day as the patients
became more fatigued. The patients in the study were
scored on the Expanded Disability Status Scale (EDSS)
scale by a neurologist. The EDSS scale measures neurological disability by assessing motor, sensory, cerebellar,
brain stem, visual, and mental abilities. Gait was measured
using the GAITRite Analysis System, a computerized mat
with sensors that measured contact of the feet with the
mat. The system combined the time and distance into a
score known as the Functional Ambulation Performance
(FAP) score. The system removed points for dysfunction
of each leg, lack of lower limb strength, and the use of assistive devices. The FAP score was highly correlated with
neurological abilities. The more neurological impairments
a patient had, the less efficient their gait. The data also
suggests that the impairments in upper motor neuron
function lead to abnormal gait in MS. Significant changes to the FAP score would suggest a relapse in the MS
(Givon, et al., 2009).
Gait Training
Conventional physical therapy involves different techniques that help patients improve gait and reduce the
risk of falls. Treatment for MS involves stretching to reduce spasticity of the muscles and maintain the patient’s
range of motion at the joints. Exercises also work toward
improving trunk control and increasing strength in the
upper arms. Physical therapists also teach MS patients
how to adapt to the environment and use aids such as
wheelchairs and braces (Schwartz et al., 2011).
Physical therapists work with patients on balance exercises as well as strength and resistance training. In the
past, Bodyweight-supported treadmill training (BWSTT)
was a popular method to improve gait in patients with
MS. BWSTT is based on the effectiveness of intensive and
task-specific gait training. The user wears a harness which
is held up and supported by the therapist. The patient has
minimal support from a rope attached to the harness and
walks on a treadmill, while the legs are physically guided
by the therapist. However, this is extremely exhausting
for both the patient and the therapist. It is also impractical for patients that have limited function of their legs
(van Kammen, et al., 2016).
A study compared walking on a treadmill regularly to
walking on a treadmill with body weight support in 10
healthy individuals. Normal gait pattern was disrupted
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when body weight support was provided. In addition, neuromuscular control of walking was affected. As gait speed
increased, the differences between walking with and without support were less pronounced. It was recommended
that higher speeds and less bodyweight support should
be provided to patients when trying to reinstate a natural
gait (van Kammen, et al., 2014).
Recently, robot-assisted gait training devices have been
recognized for their ability to provide walking assistance
to patients with severe gait disabilities. The robots, also
known as exoskeletons, allow the patient to walk on flat
ground. The parts of the exoskeleton that attach to the
lower extremities are connected to a computer. The physical therapist can use the software to manually adjust the
angles of the different parts in order to mimic the ideal gait
of the specific patient (Berriozabalgoitia, et al., 2021).
What is Ekso?
The Ekso is a robotic exoskeleton developed by Ekso
Bionics in Richmond, California. The Ekso is made of carbon fibers and steel. It functions as an exoskeleton by
attaching to the thigh, lower leg, and foot. The sensors
embedded in the attachments respond to input from the
user’s muscles. A backpack that is worn to support the
torso (Lajeunesse, et al., 2015). There are motors located
at the knees and hips. A spring-loaded footplate ensures
that the patient’s steps clear the floor. The device supports itself and does not add any additional weight to the
user.The user may require the assistance of a gait aid such
as a walker or cane at first, but eventually many patients
can walk on their own. The advanced software allows the
physical therapist to set the parameters for the level of
assistance that the robot provides, including the areas of
step height, step length, and swing speed. The purpose of
this is to promote participation from the patient in a way
that is reasonably challenging (Wee, et al., 2020).
There are three levels of assistance that the Ekso
software can provide. The lowest level, named FirstStep,
requires the physical therapist to initiate the step using
a controller. The patient is not involved in initiating the
movement. This is often used in the beginning stages of
treatment when the patient is learning to use the device.
In ActiveStep, the patient presses a button and the device initiates a step forward. The most advanced level is
ProStep, where the device moves when the patient engages in normal walking behavior such as lifting the foot and
shifting the weight forward. The Ekso is highly beneficial
because it can be programmed to work with patients that
have mild to severe gait issues (Thomassen et al., 2019).
A main goal of physical therapy in neurologically impaired patients is to recover gait. Walking is important

Can Robotic Exoskeletons Improve Gait in MS Patients?

for physical and mental wellbeing. The best outcome is
based on the principles of relative and repetitive training.
The Ekso is relative because it allows the patient to experience a real walking position. It can be used in both
indoor and outdoor environments. The Ekso training is
repetitive because the patient spends multiple sessions
walking wearing the device. Exercise that is high-intensity
and is task-specific has been shown to promote the most
progress toward recovery (Russo, et al., 2021).
Gross Motor Improvements
The trunk muscles are an integral part of maintaining
proper posture during sitting and standing. Proper posture is also the first step in achieving a normal gait. Trunk
muscles are activated systematically during walking to
keep the body steady. Faster gait speed requires higher
levels of trunk muscle engagement to keep the body stable. Engaging the trunk muscles to improve trunk function
can provide many rehabilitative benefits. As opposed to
other exoskeleton devices, Ekso requires the user to initiate the stepping movement by shifting their weight. This
requires full body weight-bearing, which forces the user
to activate their trunk muscles. Usage of the Ekso showed
an increase in trunk activity both in the anterior-posterior and medial-lateral directions.The level of trunk muscle
activation was much higher with the Ekso than voluntarily induced contraction. Research also suggested that the
voluntary stepping promoted activity in the cortical and
vestibulospinal pathways which shows the Ekso can promote neuromuscular improvement (Alamro, et al., 2018).
A study was done with 36 MS patients that required
assistance when walking outside. Both the control group
and the intervention group participated in weekly sessions with a physical therapist. However, the intervention
group engaged in biweekly training with a robotic exoskeleton for three months. The parameters of the exoskeleton were set according to each individual patient’s
motor skills and joint mobility. The length of the sessions
increased as time progressed, and endurance improved.
The sessions were stopped early if the patient requested
or if the physical therapist noticed signs of fatigue such as
increased muscle tone and stumbling. At the end of each
session cooling therapies were used on knee extensors
and ankle plantar flexors to prevent exercise-induced hyperthermia and muscle fatigue. The study displayed that
robotic gait training in addition to regular rehab sessions
preserves gait speed and improves functional mobility in patients with MS. The exoskeleton did not cause
increased fatigue in the participants. The control group
showed an overall decline in physical function. The effects
were two-fold as the symptoms did not improve, and the

disease got progressively worse. The Ekso exoskeleton is
a crucial tool in rehabilitation because it encourages cognitive control of body movements, specifically in the area
of weight shift (Berriozabalgoitia, et al., 2021).
Quality of Life Improvements
A robotic exoskeleton can also improve the quality of life
in patients with MS. The exoskeleton provides a highly repetitive and intensive gait training experience. The user is
held in an upright position while walking around. The exoskeleton is portable, which allows it to be used in any environment, including outdoors.This is engaging and rewarding
to the patient to be able to experience walking in a way
very similar to a healthy individual. A study was done with
a 51-year-old non-ambulatory patient. The goal for this patient was for her to be able to assist in transfers, to reduce
the burden on her caregivers, and to improve her quality of
life. Compared to other studies, the purpose here was not
to promote ambulation. The patient used the Ekso robotic
exoskeleton for a total of 15 sessions that occurred for one
hour twice a week. The distance covered during each session was dependent on the patient’s level of fatigue. After
the Ekso sessions, the patient showed an increase in right
knee extensor strength which made the sitting to standing
transition easier.As the therapy progressed, the patient’s endurance increased as well, and she was able to walk further
distances. There was no change in spasticity, trunk control,
or balance. However, the most notable improvement was
in the patient’s quality of life. Prior to using the exoskeleton,
the patient was depressed and did not want to participate
in social activities. After treatment, the patient expressed to
the researchers how her self-confidence and self-esteem
improved (Wee, et al., 2020).
Patients with impaired walking function are often confined to wheelchairs. However, wheelchairs do not promote muscle movement and can lead to muscle atrophy. In
addition, the patient sitting in the wheelchair is lower than
everyone that is standing, leading to feelings of inferiority.
Participants reported feeling free and independent when
using the Ekso. Additionally, patients that required walking
aids such as a walker or a cane had previously felt unsteady
while walking and feared falling. While using the Ekso, they
felt supported and secure, so they were able to focus on
the actual leg movement (Thomassen et al., 2019).
Conclusion
The impairment of gait is reported as the most debilitating symptom of MS. Although many gait training methods
have been used over the years, few have led to significant
improvements. Ekso is a new robotic exoskeleton that
has recently been trialed for its effectiveness in improving
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the gait of MS patients. Studies have shown that using
Ekso, patients’ gait and quality of life has improved. There
is hope that the Ekso will become more widely available
in order to provide more patients with the euphoric experience of walking again.
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